Two-year real-world outcomes of coronary drug-coated balloon therapy: a retrospective comparative study of sirolimus- and paclitaxel-coated devices
Therapeutic Advances in Cardiovascular Disease
Published online on July 18, 2026
Abstract
Therapeutic Advances in Cardiovascular Disease, Volume 20, January-December 2026.
Background:Drug-coated balloons (DCBs) represent a “leave-nothing-behind” strategy in percutaneous coronary intervention (PCI), particularly for small vessel disease and in-stent restenosis. However, long-term comparative real-world data between ...
Background:Drug-coated balloons (DCBs) represent a “leave-nothing-behind” strategy in percutaneous coronary intervention (PCI), particularly for small vessel disease and in-stent restenosis. However, long-term comparative real-world data between ...